Novel food: vitamin D2 mushroom powder
- Novel/traditional foods
Summary
The European Commission has authorised vitamin D2 mushroom powder as a novel food.
European Commission authorises D2 mushroom as a novel food
Commission Implementing Regulation (EU) 2023/4 of 3 January 2023 authorising the placing on the market of vitamin D2 mushroom powder as a novel food and amending Implementing Regulation (EU) 2017/2470
Update
The European Commission has authorised vitamin D2 mushroom powder as a novel food.
Impacted Products
milk analogues, dairy analogues, breakfast cereals, cereal bars, soups, fruit/vegetable juices, nectars and concentrates, energy drinks, foods for special medical purposes, food supplements
What is changing?
The EU has authorised that D2 mushroom powder may be placed on the EU market as a novel food. It may be used in a range of foods including milk analogues, dairy analogues other than milks, breakfast cereals and cereal bars, soups, fruit/ vegetable juices, nectars and concentrates, energy drinks, foods for special medical purposes for infants and young children, foods for special medical purposes, food supplements. Details on the permitted use are set out in the Annex to the Regulation.
Only the company that applied for the authorisation, Monterey Mushrooms Inc, is authorised to place the novel food on the EU market for a period of 5 years, unless another company obtains a novel food authorisation for D2 mushroom powder (without reference to scientific data protected by Monterey Mushrooms) or with the agreement of Monterey Mushrooms.
Timeline
The 5-year period of exclusive rights of Monterey Mushrooms to put this novel food on the market begins on 24 January 2023.
Background
This Regulation updates the Annex to Implementing Regulation (EU) 2017/2470 which lists authorised novel foods (see the Union list of novel foods).
Resources
European Commission: Union list of novel foods
Sources
Disclaimer: Under no circumstances shall COLEAD be liable for any loss, damage, liability or expense incurred or suffered that is claimed to have resulted from the use of information available on this website or any link to external sites. The use of the website is at the user’s sole risk and responsibility. This information platform was created and maintained with the financial support of the European Union. Its contents do not, however, reflect the views of the European Union.